Chapter 4 - Endocrine, nutritional and metabolic diseases (E00-E89)»Metabolic disorders (E70-E88)»Sanfilippo mucopolysaccharidoses (E76.22)
E76.22
Sanfilippo mucopolysaccharidoses
Related indications (MeSH) (1)
Mucopolysaccharidosis III23 drugs (8 approved, 15 experimental)
Mucopolysaccharidosis characterized by HEPARAN SULFATE in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.